HUTCHMED (China) Limited Sponsored ADR (HCM) vs Supernus Pharmaceuticals, Inc. (SUPN)
- HUTCHMED (China) Limited Sponsored ADR HCM 14.05 +0.79%
- Supernus Pharmaceuticals, Inc. SUPN 37.88 −4.27%
HUTCHMED (China) Limited Sponsored ADR and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. HUTCHMED (China) Limited Sponsored ADR and Supernus Pharmaceuticals, Inc. are of similar size ($2.4B and $2.3B). HUTCHMED (China) Limited Sponsored ADR grew revenue faster over the last twelve months: 245.2% against 24.9%. Supernus Pharmaceuticals, Inc. has the higher net margin (−13.2% vs −23.6%) and the lower return on invested capital (−12.4% vs 0.00%). Across the 16 metrics below, HUTCHMED (China) Limited Sponsored ADR leads on 9 and Supernus Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | HCM | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 44.40% | 88.07% | 53.94% |
| Operating margin | 0.00% | (15.71%) | 0.00% |
| Net margin | (23.63%) | (13.23%) | 0.00% |
| Free cash flow margin | 0.00% | 2.21% | 0.00% |
| Return on equity | 0.00% | (10.49%) | (0.40%) |
| Return on assets | 0.00% | (7.82%) | (3.32%) |
| Return on invested capital | 0.00% | (12.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack